Hengkang Medical Group Co Ltd
SZSE:002219
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.69
3.32
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Hengkang Medical Group Co Ltd
Hengkang Medical Group Co Ltd
Cash & Cash Equivalents
Hengkang Medical Group Co Ltd
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Hengkang Medical Group Co Ltd
SZSE:002219
|
Cash & Cash Equivalents
¥449.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
22%
|
CAGR 10-Years
12%
|
|
|
H
|
Hygeia Healthcare Holdings Co Ltd
HKEX:6078
|
Cash & Cash Equivalents
¥853.8m
|
CAGR 3-Years
30%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
|
|
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
Cash & Cash Equivalents
¥5.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
26%
|
CAGR 10-Years
24%
|
|
|
X
|
XiAn International Medical Investment Co Ltd
SZSE:000516
|
Cash & Cash Equivalents
¥667.3m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-3%
|
|
|
H
|
Huaxia Eye Hospital Group Co Ltd
SZSE:301267
|
Cash & Cash Equivalents
¥3.9B
|
CAGR 3-Years
98%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Sanbo Hospital Management Group Ltd
SZSE:301293
|
Cash & Cash Equivalents
¥822.1m
|
CAGR 3-Years
16%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Hengkang Medical Group Co Ltd
Glance View
Hengkang Medical Group Co. Ltd. is engaged in the manufacturing, sale, research and development of traditional Chinese medicines. The company is headquartered in Chengdu, Sichuan and currently employs 7,622 full-time employees. The company went IPO on 2008-03-06. In addition, The Company also engages in the research and development, production and manufacture of Chinese patent medicines, Chinese herbal medicines and Chinese medicinal materials, medical devices, medical institution preparations, daily chemicals and health products. The firm operates its business within the domestic market and overseas markets.
See Also
What is Hengkang Medical Group Co Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
449.3m
CNY
Based on the financial report for Sep 30, 2024, Hengkang Medical Group Co Ltd's Cash & Cash Equivalents amounts to 449.3m CNY.
What is Hengkang Medical Group Co Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
12%
Over the last year, the Cash & Cash Equivalents growth was -24%. The average annual Cash & Cash Equivalents growth rates for Hengkang Medical Group Co Ltd have been 28% over the past three years , 22% over the past five years , and 12% over the past ten years .
You don't have any saved screeners yet
